9953330565 Low Rate Call Girls In Rohini Delhi NCR
3 4 cholinergic pharmacology younus h johan 2016
1. Important drugs used in
glaucoma
Dr. Younus H JohanDr. Younus H Johan
Department of pharmacology & toxicology
College of pharmacy
University of al-anbar
2016
15. Drugs or class Nature of action and important
remarks
Cholinergic agents
Muscarinic
agonists
(pilocarpine)
Anticholinesterase
s [physostigmine,
Improved drainage of aqueous
humour (contracting the longitudinal
muscle of the ciliary body leading to
opening the trabecular meshwork
around Schlemm’s canal (drainage
channels), immediate drops [physostigmine,
DFP
(isoflurophate)]
channels), immediate drop
(IOP).
•acute glaucoma
•chronic open-angle glaucoma.
M.AK.Lafi : Essentials of Medical Pharmacology 2009
16.
17. Drugs or class Nature of action and important remarks
-blockers
Timolol
Betaxolol
Cartelol
Metipranolol
Decrease production of AH -to reduced
IOP.
No effect on focusing for near vision or
pupil size;
(used inMetipranolol (used in
chronic open-angle glaucoma,
narrow and acute glaucoma.
M.AK.Lafi : Essentials of Medical Pharmacology 2009
18. Drugs or
class
Nature of action and important remarks
α-agonists
Non-selective
Adrenaline
α2-selective
Praclonidine
Enhances AH outflow (drainage, -receptors)
by increasing PG production that enhance
uveoscleral drainage
decreases production of AH by
vasoconstriction of the ciliary body bloodPraclonidine
Brimonidine
vasoconstriction of the ciliary body blood
vessels leading to reduced IOP.
Topical 2% adrenaline solution used in chronic open-angle glaucoma.
C/I
•closed-angle
•acute glaucomas
M.AK.Lafi : Essentials of Medical Pharmacology 2009
19. Drugs or class Nature of action and important remarks
Prostaglandins
(PGF2α
derivatives:
latanoprost,
unoprostone)
Increase outflow by acting at the FP
receptor -stimulates collagenase and
metalloproteinase to degrade the
extracellular matrix between ciliary muscle
bundles, which in turn leads to the reduction
of hydraulic resistance to uveoscleral flow
SESE
•irreversible brown pigmentation of the
iris and eyelashes,
•Eyelash : lengthening, thickening
•drying of the eyes, and conjunctivitis.
M.AK.Lafi : Essentials of Medical Pharmacology 2009
20. Drugs or class Nature of action and important remarks
Diuretics
Carbonic
anhydrase
inhibitors
Acetazolamide
Decreases production of AH by blocking
carbonic anhydrase in the ciliary body
leading to reduced IOP.
•chronic glaucoma
•acute closed-angle glaucoma.•acute closed-angle glaucoma.
Osmotic agents
Mannitol
Reduces IOP in acute closed-angle
glaucoma.
M.AK.Lafi : Essentials of Medical Pharmacology 2009
23. Drug Duration Use
Tropicamide 3-6 hr Fundus examination
Homatropine 1-3 days Cycloplegic for refraction* in
children
Atropine 7-10 days For refraction as above; also
iridocyclitis**
(+ phenylephrine)
They may precipitate acute
glaucoma in the elderly and
predisposed patients
M.AK.Lafi : Essentials of Medical Pharmacology 2009
29. Selected therapeutic uses and important
remarks*
Antimuscarinic
agents
• to produce mydriasis & cycloplegia prior to
refraction (7 days)
• spastic disorders of GI and lower urinary tracts
• organophosphate poisoning
Atropine
( click )
• organophosphate poisoning
• premedication prior to surgery, to suppress
respiratory secretion in children
M.AK.Lafi : Essentials of Medical Pharmacology 2009
30. Selected therapeutic uses and important
remarks*
Antimuscarinic
agents
• to produce mydriasis & cycloplegia prior to
refraction (7 days)
• spastic disorders of GI and lower urinary tracts
• organophosphate poisoning
• premedication prior to surgery, to suppress
respiratory secretion in children
Atropine
( click )
• Cycloplegic for refraction in children (24 hr)Homatropine
• Fundus examination (3 hr)Tropicamide
M.AK.Lafi : Essentials of Medical Pharmacology 2009
31. Selected therapeutic uses and important
remarks*
Antimuscarinic
agents
• In obstetrics with morphine to produce amnesia
and sedation
Scopolamine
(hyoscine) and sedation
• Motion sickness
(hyoscine)
• Asthma (inhalation)Ipratropium
M.AK.Lafi : Essentials of Medical Pharmacology 2009
32. Selected therapeutic uses and important
remarks*
Antimuscarinic
agents
• With chlordiazepoxide (Librax®) in GI disorders like
• peptic ulcer,
• nervous dyspepsia,
• irritable bowel syndrome,
• spastic colitis,
• mild ulcerative colitis
Clidinium
With trifluoperazine (Stelabid®) in
• peptic ulcer,
• visceral spasm
Isopropamide
• Peptic ulcer (inhibits acid secretion),Pirenzepine • Peptic ulcer (inhibits acid secretion),
• poorly enters the CNS, thus, no or little CNS side-effects
Pirenzepine
• Peptic ulcer,
• irritable bowel syndrome, &
• urinary disorders of storage (urinary frequency,
incontinence, nocturnal enuresis
Propantheline
• Urinary disorders of storage (as above)Emepronium
(Cetiprin®)
M.AK.Lafi : Essentials of Medical Pharmacology 2009
33. Selected therapeutic uses and important
remarks*
Antimuscarinic
agents
• Peptic ulcer (inhibits acid secretion),
• poorly enters the CNS, thus, no or little CNS side-effects
Pirenzepine
• Peptic ulcer,
• irritable bowel syndrome, &
Propantheline
• irritable bowel syndrome, &
• urinary disorders of storage (urinary frequency,
incontinence, nocturnal enuresis
• Urinary disorders of storage (as above)Emepronium
(Cetiprin®)
M.AK.Lafi : Essentials of Medical Pharmacology 2009
34. CNS Agents
Benzotropine
(Centrally acting antimuscarinic antagonists)
• Drug induced dystonias
• Parkinson’s disease
Benzotropine
Procyclidine
Benzhexol-HCl
Orphenadrine
Adverse-effects commonly observed with cholinergic antagonists:
blurred vision, mydriasis, tachycardia, constipation, urinary retention, and confusion.
M.AK.Lafi : Essentials of Medical Pharmacology 2009
35. Moderately severe to severe hypertension
Ganglionic
blockers
MecamylamineMecamylamine
Short-term treatment of hypertension (emergency
lowering of blood pressure, when other agents cannot be
used)
Trimethaphan
M.AK.Lafi : Essentials of Medical Pharmacology 2009
36. See appropriate section in the chapter on CNS
pharmacology (later on)
Neuromuscular
blockers
Nondepolarising
(competitive agents)(competitive agents)
Depolarising agents
M.AK.Lafi : Essentials of Medical Pharmacology 2009